Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. Among authors: yamazaki t. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
[The role of PPARgamma in the onset of type 2 diabetes].
Hara K, Yamauchi T, Kubota N, Tobe K, Yamazaki T, Nagai R, Kadowaki T. Hara K, et al. Among authors: yamazaki t. Nihon Yakurigaku Zasshi. 2003 Oct;122(4):317-24. doi: 10.1254/fpj.122.317. Nihon Yakurigaku Zasshi. 2003. PMID: 14501167 Review. Japanese.
Management of home blood pressure by amlodipine combined with angiotensin II receptor blocker in type 2 diabetes.
Miyauchi K, Yamazaki T, Watada H, Tanaka Y, Kawamori R, Imai Y, Ikeda S, Kitagawa A, Ono Y, Murayama F, Choi JB, Suwa S, Hayashi D, Kishimoto J, Daida H; ADVANCED-J investigators. Miyauchi K, et al. Among authors: yamazaki t. Circ J. 2012;76(9):2159-66. doi: 10.1253/circj.cj-11-1406. Epub 2012 Jun 9. Circ J. 2012. PMID: 22785573 Free article. Clinical Trial.
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.
Inazawa T, Sakamoto K, Kohro T, Iijima R, Kitazawa T, Hirano T, Kawamura M, Tagami M, Tanaka A, Mori Y, Yamazaki T, Shiba T; RESEARCH Study Group. Inazawa T, et al. Among authors: yamazaki t. Lipids Health Dis. 2013 Oct 5;12:142. doi: 10.1186/1476-511X-12-142. Lipids Health Dis. 2013. PMID: 24094079 Free PMC article. Clinical Trial.
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Sakamoto K, Kawamura M, Kohro T, Omura M, Watanabe T, Ashidate K, Horiuchi T, Hara H, Sekine N, Chin R, Tsujino M, Hiyoshi T, Tagami M, Tanaka A, Mori Y, Inazawa T, Hirano T, Yamazaki T, Shiba T; RESEARCH Study Group. Sakamoto K, et al. Among authors: yamazaki t. PLoS One. 2015 Sep 23;10(9):e0138332. doi: 10.1371/journal.pone.0138332. eCollection 2015. PLoS One. 2015. PMID: 26398887 Free PMC article. Clinical Trial.
Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial.
Ueshima K, Itoh H, Kanazawa N, Komuro I, Nagai R, Takeuchi M, Yamazaki T; EMPATHY study group. Ueshima K, et al. Among authors: yamazaki t. J Atheroscler Thromb. 2016 Aug 1;23(8):976-90. doi: 10.5551/jat.33563. Epub 2016 Mar 8. J Atheroscler Thromb. 2016. PMID: 26961114 Free PMC article. Clinical Trial.
3,702 results